1. Home
  2. TRMK vs IRON Comparison

TRMK vs IRON Comparison

Compare TRMK & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$42.93

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.70

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
IRON
Founded
1889
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRMK
IRON
Price
$42.93
$69.70
Analyst Decision
Hold
Strong Buy
Analyst Count
2
11
Target Price
$44.50
$103.18
AVG Volume (30 Days)
292.5K
432.1K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.26%
N/A
EPS Growth
1.93
N/A
EPS
0.95
N/A
Revenue
N/A
N/A
Revenue This Year
$9.82
N/A
Revenue Next Year
$4.86
$283.52
P/E Ratio
$46.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.39
$40.00
52 Week High
$45.99
$99.50

Technical Indicators

Market Signals
Indicator
TRMK
IRON
Relative Strength Index (RSI) 41.55 54.30
Support Level $38.73 $64.39
Resistance Level $43.29 $71.53
Average True Range (ATR) 0.87 3.20
MACD -0.12 0.20
Stochastic Oscillator 8.47 72.29

Price Performance

Historical Comparison
TRMK
IRON

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: